Lake Street Maintains Buy on Better Therapeutics, Lowers Price Target to $3
Lake Street Maintains Buy on Better Therapeutics, Lowers Price Target to $3
Lake Street維持對Better Therapeutics的買入，將目標股價
Lake Street analyst Thomas Flaten maintains Better Therapeutics (NASDAQ:BTTX) with a Buy and lowers the price target from $5 to $3.
Lake Street分析師托馬斯·弗拉滕維持Better Therapeutics（納斯達克股票代碼：BTTX）的買入，並將目標股價從5美元下調至3美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。